# Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma

> **NCT06764537** · NA · NOT_YET_RECRUITING · sponsor: **Central Hospital, Nancy, France** · enrollment: 18 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **PROCEDURE:** Blood collection

## Key facts

- **NCT ID:** NCT06764537
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06764537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06764537, "Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06764537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*